Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Avnalit 4mg
Connect with this vendor - Learn about this product

AVNALIT 4MG – Lenvatinib Capsules IP 4mg

Avnalit 4mg

Composition: Lenvatinib Capsules IP 4mg

Dosage Form:  Capsules

Packing: 30 Capsules

Market Authorization: MBA Pharmaceuticals Pvt Ltd

Country of Origin: India

Lenvatinib is used to treat a certain type of thyroid cancer that has returned or that has spread to other parts of the body and cannot be treated with radioactive iodine.